Kiromic BioPharma, Inc. (KRBP)

OTCMKTS: KRBP · Delayed Price · USD
0.300
0.00 (0.00%)
Nov 27, 2023, 2:04 PM EST - Market open

Kiromic BioPharma Market Cap

Kiromic BioPharma has a market cap or net worth of $314.62 thousand as of November 28, 2023. Its market cap has decreased by -95.23% in one year.

Market Cap
314.62K
Enterprise Value
7.29M
1-Year Change
-95.23%
Ranking
n/a
Category
Stock Price
$0.30

Market Cap Chart

Since the IPO on October 16, 2020, Kiromic BioPharma's market cap has decreased from $88.00M to $314.62K, a decrease of -99.64%. That is a compound annual growth rate of -85.58%.

History

DateMarket Cap% Change
Sep 13, 20231.70M
-10.53%
Sep 12, 20231.90M
5.56%
Sep 11, 20231.80M-
Sep 8, 20231.80M-
Sep 7, 20231.80M
-5.26%
Sep 6, 20231.90M
-13.64%
Sep 5, 20232.20M
4.76%
Sep 1, 20232.10M
-4.55%
Aug 31, 20232.20M
4.76%
Aug 30, 20232.10M
-8.70%
Aug 29, 20232.30M-
Aug 28, 20232.30M
9.52%
Aug 25, 20232.10M
-4.55%
Aug 24, 20232.20M
-4.35%
Aug 23, 20232.30M
-8.00%
Aug 22, 20232.50M
-3.85%
Aug 21, 20232.60M-
Aug 18, 20232.60M
-3.70%
Aug 17, 20232.70M-
Aug 16, 20232.70M
-3.57%
Aug 15, 20232.80M-
Aug 14, 20232.80M
27.27%
Aug 11, 20232.20M
-4.35%
Aug 10, 20232.30M-
Aug 9, 20232.30M-
View and export this data all the way back to 2020. Start Free Trial.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 570.63B
UnitedHealth Group 506.03B
Novo Nordisk 470.41B
Johnson & Johnson 367.11B
Merck & Co. 258.14B
AbbVie 244.83B
Novartis AG 201.72B
AstraZeneca 199.94B
Market Cap Rankings